# An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

> **NCT00678743** · PHASE4 · COMPLETED · sponsor: **Provident Clinical Research** · enrollment: 17 (actual)

## Conditions studied

- Dyslipidemias

## Interventions

- **DRUG:** Omacor + simvastatin

## Key facts

- **NCT ID:** NCT00678743
- **Lead sponsor:** Provident Clinical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00678743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00678743, "An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00678743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*